---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-021066"
form_type: "8-K"
ticker: "IBO"
cik: "0001834105"
company_name: "IMPACT BIOMEDICAL INC."
filed_at: "2025-11-06T23:59:59+00:00"
generated_at: "2026-05-16T23:58:30.214302+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Impact Biomedical shareholders elect directors, ratify auditor, approve say-on-pay at 2025 annual meeting

## Summary
- All eight director nominees elected with ~61.5M votes each; broker non-votes of ~2.7M.
- Ratification of Grassi & Co. as auditor for FY2025 received 64.1M votes for, 174k against.
- Advisory say-on-pay approved: 61.5M for, 108k against, 2.7M broker non-votes.
- Quorum of 88.5% of outstanding shares (64.3M shares) represented at the meeting.

## SEC filing metadata
- accession: 0001493152-25-021066
- form_type: 8-K
- ticker: IBO
- cik: 0001834105
- company_name: IMPACT BIOMEDICAL INC.
- filed_at: 2025-11-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1834105/000149315225021066/0001493152-25-021066-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1834105/000149315225021066/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-021066
- JSON: https://secwatch.observer/filing/0001493152-25-021066.json
- Plain text: https://secwatch.observer/filing/0001493152-25-021066.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.